ATE382054T1 - Verwendung von oxytocinfragmenten zur herstellung einer pharmazeutischen zusammensetzung zum bewirken von eustasis - Google Patents
Verwendung von oxytocinfragmenten zur herstellung einer pharmazeutischen zusammensetzung zum bewirken von eustasisInfo
- Publication number
- ATE382054T1 ATE382054T1 AT02739051T AT02739051T ATE382054T1 AT E382054 T1 ATE382054 T1 AT E382054T1 AT 02739051 T AT02739051 T AT 02739051T AT 02739051 T AT02739051 T AT 02739051T AT E382054 T1 ATE382054 T1 AT E382054T1
- Authority
- AT
- Austria
- Prior art keywords
- pharmaceutical composition
- eustasis
- oxytocin
- aciding
- preparing
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/08—Tripeptides
- C07K5/0821—Tripeptides with the first amino acid being heterocyclic, e.g. His, Pro, Trp
- C07K5/0823—Tripeptides with the first amino acid being heterocyclic, e.g. His, Pro, Trp and Pro-amino acid; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/26—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against hormones ; against hormone releasing or inhibiting factors
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
- C07K5/06008—Dipeptides with the first amino acid being neutral
- C07K5/06017—Dipeptides with the first amino acid being neutral and aliphatic
- C07K5/06034—Dipeptides with the first amino acid being neutral and aliphatic the side chain containing 2 to 4 carbon atoms
- C07K5/06043—Leu-amino acid
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/08—Tripeptides
- C07K5/0802—Tripeptides with the first amino acid being neutral
- C07K5/0804—Tripeptides with the first amino acid being neutral and aliphatic
- C07K5/081—Tripeptides with the first amino acid being neutral and aliphatic the side chain containing O or S as heteroatoms, e.g. Cys, Ser
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/10—Tetrapeptides
- C07K5/1002—Tetrapeptides with the first amino acid being neutral
- C07K5/1005—Tetrapeptides with the first amino acid being neutral and aliphatic
- C07K5/1013—Tetrapeptides with the first amino acid being neutral and aliphatic the side chain containing O or S as heteroatoms, e.g. Cys, Ser
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/16—Oxytocins; Vasopressins; Related peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biochemistry (AREA)
- Endocrinology (AREA)
- Immunology (AREA)
- Psychiatry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Pain & Pain Management (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE0102184A SE0102184D0 (sv) | 2001-06-19 | 2001-06-19 | New subject-matter |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE382054T1 true ATE382054T1 (de) | 2008-01-15 |
Family
ID=20284539
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT02739051T ATE382054T1 (de) | 2001-06-19 | 2002-06-19 | Verwendung von oxytocinfragmenten zur herstellung einer pharmazeutischen zusammensetzung zum bewirken von eustasis |
Country Status (6)
Country | Link |
---|---|
US (1) | US7714105B2 (de) |
EP (1) | EP1409518B1 (de) |
AT (1) | ATE382054T1 (de) |
DE (1) | DE60224280D1 (de) |
SE (1) | SE0102184D0 (de) |
WO (1) | WO2002102832A1 (de) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR101155740B1 (ko) * | 2004-03-31 | 2012-06-12 | 톳쿄기쥬츠 가이하츠 가부시키가이샤 | 상피계 세포증식 촉진제 |
FR2954167A1 (fr) | 2009-09-04 | 2011-06-24 | Centre Nat Rech Scient | Traitement par l'ocytocine de caracteristiques comportementales associees a l'autisme et a la timidite pathologique |
SE536091C2 (sv) | 2011-04-14 | 2013-04-30 | Pep Tonic Medical Ab | Farmaceutisk komposition innehållande oxytocin eller fragment eller varianter därav och åtminstone en icke-jonisk cellulosaeter |
SI3242676T1 (sl) | 2015-01-07 | 2024-02-29 | Tonix Pharma Limited | Formulacije oksitocina, ki vsebujejo magnezij in načini uporabe |
JP6527996B2 (ja) * | 2017-09-12 | 2019-06-12 | 株式会社 金冠堂 | Fgf活性に影響を与えるジペプチド |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4271068A (en) * | 1968-05-10 | 1981-06-02 | Ciba-Geigy Corporation | Process for the manufacture of cystine-containing peptides |
EP0146113A3 (de) * | 1983-12-15 | 1987-08-19 | Dieter Aderhold | Wirkstoff und therapeutisches Mittel zur Behandlung von Fehlfunktionen des Diencephalon, von Nervenerkrankungen und Erkrankungen der Haut |
US5767083A (en) * | 1994-05-04 | 1998-06-16 | Innapharma, Inc. | Tri-, tetra-, penta-, and polypeptides and their therapeutic use as an antidepressant agent |
SE9803271D0 (sv) | 1998-09-25 | 1998-09-25 | Kerstin Uvnaes Moberg | A drug for well-being |
-
2001
- 2001-06-19 SE SE0102184A patent/SE0102184D0/xx unknown
-
2002
- 2002-06-19 US US10/481,623 patent/US7714105B2/en not_active Expired - Lifetime
- 2002-06-19 DE DE60224280T patent/DE60224280D1/de not_active Expired - Lifetime
- 2002-06-19 AT AT02739051T patent/ATE382054T1/de not_active IP Right Cessation
- 2002-06-19 WO PCT/SE2002/001207 patent/WO2002102832A1/en active IP Right Grant
- 2002-06-19 EP EP02739051A patent/EP1409518B1/de not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
EP1409518B1 (de) | 2007-12-26 |
EP1409518A1 (de) | 2004-04-21 |
US7714105B2 (en) | 2010-05-11 |
SE0102184D0 (sv) | 2001-06-19 |
WO2002102832A1 (en) | 2002-12-27 |
US20040259805A1 (en) | 2004-12-23 |
DE60224280D1 (de) | 2008-02-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK1049767T3 (da) | En transgen kanin, der udtrykker et funktionelt humant lipoprotein(A) | |
BRPI9912663B1 (pt) | vacina contra cáncer e polipeptìdeo. | |
BR0012243A (pt) | Triflúor butenos nematocidas | |
IL202249A (en) | Nucleic Acids Encoders Human Immunodeficiency Strange Type 1 (HIV – 1) Group M Consensus Envelope Glycoproteins | |
MX2009007145A (es) | Conjugados de polimero con factor viii y factor de von willebrand que tienen una ligadura liberable. | |
DE69922958D1 (de) | Hcv hüllproteine partikel : verwendung für therapeutische impfung | |
YU71901A (sh) | NOVE VRSTE LEKOVITIH KOMPOZICIJA NA BAZI JEDINJENJA KOJA DELUJU ANTIHOLINERGIJSKI I beta-MIMETIKA | |
ATE446313T1 (de) | Muteine von tränen-lipocalin | |
DE60222644D1 (de) | Prozess zur herstellung von transparenten formteilen | |
DE60318831D1 (de) | System zur abgabe von anästhetika | |
BR0318278A (pt) | compostos de éter aminocicloexìlico e usos dos mesmo | |
DE60129518D1 (de) | Verwendung von einem Vasopressin-Antagonisten wie Conivaptan zur Herstellung eines Medikaments für die Behandlung der pulmonalen Hypertension | |
DE60021381D1 (de) | Chinonverbindungen zur behandlung von krankheiten | |
ATE443722T1 (de) | Peptide und peptidderivate, ihre herstellung sowie ihre verwendung zur herstellung einer therapeutisch und/oder prophylaktisch wirksamen pharmazeutischen zusammensetzung | |
ATE382054T1 (de) | Verwendung von oxytocinfragmenten zur herstellung einer pharmazeutischen zusammensetzung zum bewirken von eustasis | |
UA107177C2 (uk) | Імуногенна композиція цвс2 та спосіб приготування такої композиції | |
ATE504309T1 (de) | Verwendung von oxytocin zur herstellung einer pharmazeutischen zusammensetzung gegen karzinom in situ und zervizitis | |
DE60033207D1 (de) | Werkzeug zur herstellung von nockenwellen durch einwalzen | |
EA200301151A1 (ru) | Вакцина против натуральной оспы | |
DE50304242D1 (de) | Verfahren zur herstellung von acylphosphinoxiden | |
DE60328456D1 (de) | Eine kontinuierliche zellinie zur herstellung von impfstoffen | |
DE60227896D1 (de) | Verfahen zur Herstellung von Polyalkylphenoxyaminoalkanen | |
DE60233180D1 (de) | Verfahren zur Herstellung von Rutheniumperovskit | |
MXPA05007901A (es) | Terapia de combinacion para hcv. | |
ATE499383T1 (de) | Eine methode zur herstellung von menschlichem natürlichem interferon-alpha |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |